Yidu Tech Inc. has announced its annual results for the fiscal year ended 31 March 2025. The company reported total revenue of RMB715.0 million, marking an 11.4% decrease from the previous year. This decline was attributed to changes in the external market environment and product portfolios. Despite the revenue drop, Yidu Tech managed to narrow its loss for the year to RMB135.2 million, a 38.9% reduction compared to the prior year. The company's Life Sciences Solutions segment experienced a significant revenue decrease of 23.7%, totaling RMB247.1 million. Meanwhile, the Big Data Platform and Solutions segment saw a 10.3% increase in revenue, amounting to RMB345.9 million. The Health Management Platform and Solutions segment reported a 28.0% decline in revenue, reaching RMB122.0 million. Yidu Tech highlighted improvements in internal operational efficiency and enhanced synergies among business segments as contributing factors to the reduced loss. The company also reported a decrease in net cash outflow from operating activities by 23.8% year-on-year. As of 31 March 2025, the company maintained sufficient cash reserves, with cash and cash equivalents, term deposits, and other bank balances totaling RMB3,309.1 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.